Use of predictive probabilities in phase II and phase III clinical trials
- PMID: 10091910
- DOI: 10.1081/BIP-100101000
Use of predictive probabilities in phase II and phase III clinical trials
Abstract
Predictive probability is particularly useful in aiding a decision-making process related to drug development. This is especially true for decisions occurring as the result of interim analyses of clinical trials. Examples of clinical trial applications of Bayesian predictive probability and the use of the beta-binomial distribution are described.
MeSH terms
LinkOut - more resources
Full Text Sources